| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 749 | 681 | +10.0% |
| EBITDA | 99.8 | 83.2 | +20.0% |
| EBITDA margin | 13.3% | 12.2% | +1.1 pts |
| Profit before tax | 77.9 | 71.4 | +9.1% |
| Net profit | 70.9 | 67.4 | +5.3% |
| EPS | ₹4.18 | ₹4.03 | +3.7% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 2,673 | — | — | — | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 33.7 | 33.7 | 41.1 | 50.8 | 60.1 | ||
| 14.1 | 14.1 | 20.4 | 27.1 | 31.3 | ||
| 74.9 | 74.9 | 75.8 | 76.9 | 89.5 | ||
| 2,728 | — | — | — | — | ||
| 2,785 | 2,717 | 2,516 | 2,339 | 2,321 | ||
| — | +8.0% | +7.5% | +0.8% | — | ||
| 367 | 351 | 313 | 305 | 202 | ||
| 13.2% | 12.9% | 12.4% | 13.0% | 8.7% | ||
| 286 | 275 | 252 | 246 | 146 | ||
| 257 | 270 | 259 | 257 | 168 | ||
| 9.2% | 10.0% | 10.3% | 11.0% | 7.2% | ||
| ₹16.32 | ₹16.18 | ₹15.55 | ₹15.30 | ₹10.05 | ||
| — | +4.0% | +1.7% | +52.2% | — | ||
| — | 289 | 156 | 274 | 208 | ||
| — | −63.6 | −67.9 | −52.6 | −52.4 | ||
| 226 | 226 | 88.3 | 222 | 155 | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 2,673.0 | |
| - Cash, Equiv & ST Investments | 60.1 | 50.8 | 41.1 | 33.7 | 33.7 | |
| + Minority Interest | 31.3 | 27.1 | 20.4 | 14.1 | 14.1 | |
| + Total Debt | 89.5 | 76.9 | 75.8 | 74.9 | 74.9 | |
| Enterprise Value | — | — | — | — | 2,728.2 | |
| Revenue | 2,321.5 | 2,339.2 | 2,515.6 | 2,717.0 | 2,785.1 | |
| Growth %, YoY | — | +0.8 | +7.5 | +8.0 | — | |
| EBITDA | 202.4 | 304.7 | 312.6 | 350.8 | 367.5 | |
| Margin % | 8.72 | 13.02 | 12.43 | 12.91 | 13.19 | |
| EBIT | 145.6 | 245.5 | 252.3 | 274.7 | 286.2 | |
| Net Income | 167.6 | 257.4 | 259.3 | 270.3 | 257.2 | |
| Margin % | 7.22 | 11.00 | 10.31 | 9.95 | 9.23 | |
| EPS, Adj (current shares) | 10.05 | 15.30 | 15.55 | 16.18 | 16.32 | |
| Growth %, YoY | — | +52.2 | +1.7 | +4.0 | — | |
| Cash from Operations | 207.8 | 274.2 | 156.2 | 289.2 | — | |
| Capital Expenditures | -52.4 | -52.6 | -67.9 | -63.6 | — | |
| Free Cash Flow | 155.4 | 221.6 | 88.3 | 225.6 | 225.6 | |
Prices at the 30 October 2026 close · figures from the company's filings with NSE
Balmer Lawrie & (NSE: BALMLAWRIE) had a market capitalisation of ₹2,657 crore at the 30 October 2026 close (₹155.38 a share), a PE ratio of 9.5 on the last four quarters' profit and a price-to-book ratio of 1.28. In FY26 its consolidated net profit was ₹277 crore on revenue of ₹2,717 crore; in Q1 FY27 (April–June 2026) it was ₹71.4 crore, up 3.6% year on year. Its debt-to-equity ratio was 0.04 on 31 March 2026.
Balmer Lawrie &'s PE ratio is 9.5 at the 30 October 2026 close (₹155.38 a share): a market capitalisation of ₹2,657 crore divided by consolidated net profit of ₹279 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹277 crore) it is 9.6.
Balmer Lawrie &'s debt-to-equity ratio was 0.04 on 31 March 2026: borrowings of ₹74.9 crore against total equity of ₹2,083 crore. A year earlier, on 31 March 2025, it was 0.04.
Balmer Lawrie &'s net worth — shareholders' equity in its consolidated balance sheet — was ₹2,069 crore on 31 March 2026, up 5.1% from ₹1,969 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹2,657 crore at the 30 October 2026 close.
Balmer Lawrie &'s price-to-book (PB) ratio is 1.28 at the 30 October 2026 close: a market capitalisation of ₹2,657 crore divided by shareholders' equity (book value) of ₹2,069 crore on 31 March 2026. That is a book value of ₹120.99 per share against a share price of ₹155.38.
In FY26, Balmer Lawrie &'s return on equity (ROE) was 13.7% and its return on capital employed (ROCE) was 11.2%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 14.0% and ROCE 11.2%.
Balmer Lawrie &'s book value per share was ₹120.99 on 31 March 2026: shareholders' equity of ₹2,069 crore divided by the 17.1 crore shares in issue, up 5.1% from ₹115.12 a year earlier. The share price at the 30 October 2026 close was ₹155.38.
Balmer Lawrie &'s market capitalisation was ₹2,657 crore at the 30 October 2026 close: 17.1 crore shares at ₹155.38 each.
No. Balmer Lawrie & had borrowings of ₹74.9 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.04. Its cash and current investments were ₹453 crore, so it held net cash of ₹378 crore.
Balmer Lawrie &'s basic earnings per share (EPS) were ₹16.18 in FY26, against ₹15.55 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹16.33.
Balmer Lawrie &'s dividend yield is 5.47% at the 30 October 2026 close: dividends of ₹8.50 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹155.38. They were ₹4.25 on 11 September 2026 and ₹4.25 on 11 March 2026 (interim).
In 2026, Balmer Lawrie & has declared two dividends totalling ₹8.50 a share: ₹4.25 (interim) with record date 11 March 2026 and ₹4.25 with record date 14 September 2026 and ex-date 11 September 2026.
In FY26, Balmer Lawrie & generated ₹289 crore of cash from operations and spent ₹63.6 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹226 crore. In FY25 it was ₹88.3 crore.
Balmer Lawrie & has no promoter group: on 30 September 2026 promoters held 0% of its shares, according to the shareholding pattern filed with NSE. Foreign portfolio investors held 2.38% and domestic institutions 1.79%.
Balmer Lawrie &'s latest results are for Q1 FY27 (April–June 2026), filed on 1 August 2026: consolidated net profit ₹71.4 crore, up 3.6% from ₹68.9 crore in Q1 FY26; revenue from operations ₹749 crore, up 10.0% year on year.
Balmer Lawrie & will announce its Q2 FY27 results (July–September 2026) on Monday, 2 November 2026, the date of the board meeting it has notified to the exchanges.
On 30 September 2026, Balmer Lawrie &'s shares were held by foreign portfolio investors (FII/FPI) 2.38%, domestic institutions (DII) 1.79% (including mutual funds at 0.00%) and retail and other non-institutional investors 95.80%. Over the year, FII holding was up 0.13 percentage points from 2.25% and DII holding was unchanged.
In FY26 (April 2025–March 2026), Balmer Lawrie &'s consolidated net profit was ₹277 crore, up 4.0% from ₹266 crore in FY25, on revenue from operations of ₹2,717 crore (up 8.0%). Over three years, from FY23, net profit was up 61.0%.
At the 30 October 2026 closing prices, on FY26 net profit, Balmer Lawrie &'s PE ratio is 9.6, the lowest of the four: DCM Shriram 16.0, TTK Healthcare 19.5 and Godrej Industries 24.6, a peer average of 20.0. Each is the company's market capitalisation at that price divided by its FY26 net profit.
On FY26 consolidated figures, against DCM Shriram, TTK Healthcare and Godrej Industries: Balmer Lawrie &'s operating margin of 10.1% is the highest of the four (DCM Shriram 7.0%, TTK Healthcare 2.0%, Godrej Industries 7.8%; peer average 5.6%); its return on equity of 13.7% is the highest of the four (DCM Shriram 11.6%, TTK Healthcare 6.0%, Godrej Industries 11.6%; peer average 9.8%); its revenue growth over three years of 5.4% a year is the lowest of the four (DCM Shriram 5.7% a year, TTK Healthcare 5.7% a year, Godrej Industries 9.9% a year; peer average 7.1% a year).
In FY26, Balmer Lawrie & earned net profit of ₹277 crore on revenue of ₹2,717 crore, against ₹853 crore on ₹14,264 crore for DCM Shriram. Balmer Lawrie &'s operating margin was 10.1% (DCM Shriram 7.0%) and its return on equity 13.7% (DCM Shriram 11.6%). At the 30 October 2026 close, Balmer Lawrie &'s market capitalisation was ₹2,657 crore against ₹13,630 crore for DCM Shriram, and its PE ratio on FY26 profit 9.6 against 16.0.
From Balmer Lawrie &'s own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 30 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.